{
    "nct_id": "NCT05751434",
    "official_title": "Phase 2 Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer",
    "inclusion_criteria": "* Age â‰¥ 18\n* Men with histologically confirmed localized prostate cancer undergoing active surveillance.\n* Inactive, defined as not meeting the national exercise guidelines for cancer patients (<150 minutes/week of moderate or vigorous exercise)43 as assessed by remote activity and heart rate tracking for a 7-day period prior to study entry (general physical activity screening assessment via smart watch).\n* Screening clearance by an MSK Exercise Physiologist (i.e., review of ECG)\n* BMI <40 kg/m^2\n* Cleared for exercise participation as per pre-screening clearance via the Physical Activity Readiness Questionnaire (PAR-Q+) (Appendix B)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Enrollment in any other program that may alter the impact of exercise on tumor outcomes (e.g., weight loss program)\n* Any neoadjuvant anticancer treatment of any kind for prostate cancer in the last 5 years\n* Any history of systemic anticancer therapy in the last 15 years\n* Distant metastatic malignancy of any kind\n* Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation",
    "miscellaneous_criteria": ""
}